Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma

被引：0
|
作者：
Slesur, Lauren [1 ]
Vilgelm, Anna [2 ]
Al-Rohil, Rami [1 ]
Richmond, Ann [2 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B166
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
    Portman, Neil
    Milioli, Heloisa
    Alexandrou, Sarah
    Coulson, Rhiannon
    Yong, Aliza
    Fernandez, Kristine
    Chia, KeeMing
    Halilovic, Ensar
    Segara, Davendra
    Parker, Andrew
    Haupt, Sue
    Haupt, Ygal
    Tilley, Wayne
    Swarbrick, Alex
    Caldon, Liz
    Lim, Elgene
    CANCER RESEARCH, 2021, 81 (04)
  • [22] The Utility of MDM2 and CDK4 Staining in Head and Neck Osteosarcoma
    Limbach, Abberly Lott
    Mostofi, Reza
    Lingen, Mark
    Cipriani, Nicole
    MODERN PATHOLOGY, 2015, 28 : 327A - 327A
  • [23] Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
    Laroche-Clary, Audrey
    Chaire, Vanessa
    Algeo, Marie-Paule
    Derieppe, Marie-Alix
    Loarer, Francois L.
    Italiano, Antoine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [24] MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones
    Bahceci, Dorukhan H.
    Jordan, Richard C. K.
    Horvai, Andrew E.
    HEAD & NECK PATHOLOGY, 2022, 16 (04): : 991 - 997
  • [25] Combined targeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas
    Audrey Laroche-Clary
    Vanessa Chaire
    Marie-Paule Algeo
    Marie-Alix Derieppe
    François L. Loarer
    Antoine Italiano
    Journal of Hematology & Oncology, 10
  • [26] MDM2 Gene Amplification and Expression of MDM2 and CDK4 are Rare in Ossifying Fibroma of Craniofacial Bones
    Dorukhan H. Bahceci
    Richard C. K. Jordan
    Andrew E. Horvai
    Head and Neck Pathology, 2022, 16 : 991 - 997
  • [27] MDM2 AND CDK4 GENE AMPLIFICATION IN EWINGS-SARCOMA
    LADANYI, M
    LEWIS, R
    JHANWAR, SC
    GERALD, W
    HUVOS, AG
    HEALEY, JH
    JOURNAL OF PATHOLOGY, 1995, 175 (02): : 211 - 217
  • [28] MicroRNA-129 Inhibits Glioma Cell Growth by Targeting CDK4, CDK6, and MDM2
    Moradimotlagh, Atieh
    Arefian, Ehsan
    Valojerdi, Rezvan Rezazadeh
    Ghaemi, Shokoofeh
    Adegani, Fatemeh Jamshidi
    Soleimani, Masoud
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 759 - 764
  • [29] MDM2 and CDK4 amplifications are rare events in salivary duct carcinomas
    Gruenewald, Inga
    Trautmann, Marcel
    Busch, Alina
    Bauer, Larissa
    Huss, Sebastian
    Schweinshaupt, Petra
    Vollbrecht, Claudia
    Odenthal, Margarete
    Quaas, Alexander
    Buettner, Reinhard
    Meyer, Moritz F.
    Beutner, Dirk
    Huettenbrink, Karl-Bernd
    Wardelmann, Eva
    Stenner, Markus
    Hartmann, Wolfgang
    ONCOTARGET, 2016, 7 (46) : 75261 - 75272
  • [30] Expression of MDM2 and CDK4 in angiomyolipomas: A potential pitfall in differential diagnosis
    Nascimento, A. F.
    Dal Cin, P.
    Hornick, J. L.
    MODERN PATHOLOGY, 2008, 21 : 173A - 173A
12345